Late last year, the U.S. Food & Drug Administration (FDA) handed a blow to pSivida by turning down its request to market its lead product, Iluvien (an investigational drug for diabetic...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)